Michaela Mueller

Ms. Michaela Mueller serves as the Chief Financial Officer and Corporate Secretary with responsibility for all Finance, Accounting, Risk Management, Legal and Information Technology functions.

In a career spanning 20 years Ms. Mueller brings a proven track record of strategic executive leadership in international and domestic financial management. Her career began with Wenzel Logistics GmbH Group in Austria, where she was employee number one and served in leadership positions that grew the company, across multiple periods of dynamic growth, from start-up to 250 employees. With her move to the United States, Ms Mueller entered the high-tech, life sciences industry holding a variety of senior level financial management positions in software and medical device companies.

Prior to joining Pharmatech Ms. Mueller served as Director of Finance at Spinal Modulation Inc, a medical device R&D and manufacturing company, where she managed the financial reporting and control for all functional areas, the international commercial launch of their first products as well as the ongoing FDA Clinical trials in the US. With the successful completion of the US Clinical Trials, Spinal Modulation was acquired by St. Jude Medical and subsequently by Abbott Laboratories. Ms. Mueller was asked to remain on the team managing all financial reporting and control for the companies transitions and integration with St. Jude and Abbott. Throughout her career she has met the global challenges of complex business strategies in high growth market segments. Ms Mueller holds an MBA in General Management from Joseph Schumpeter Institute, Austria and certificates for continuing education programs from Stanford Graduate School of Business and the Harvard Management Mentor Program.